Imugene Gross Profit from 2010 to 2024

Stocks . Australia . 
Stock . Imugene
IMU Stock   0.04  0  5.41%   
Imugene Gross Profit yearly trend continues to be comparatively stable with very little volatility. Gross Profit is likely to outpace its year average in 2024. Gross Profit is the profit Imugene makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals
 
Gross Profit  
First Reported
1994-12-31
Previous Quarter
7 M
Current Value
8.1 M
Quarterly Volatility
1.7 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Imugene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Imugene's main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.1 M, Interest Expense of 502.3 K or Other Operating Expenses of 148 M, as well as many indicators such as . Imugene financial statements analysis is a perfect complement when working with Imugene Valuation or Volatility modules.
  
This module can also supplement various Imugene Technical models . Check out the analysis of Imugene Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Imugene Stock Analysis

When running Imugene's price analysis, check to measure Imugene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imugene is operating at the current time. Most of Imugene's value examination focuses on studying past and present price action to predict the probability of Imugene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imugene's price. Additionally, you may evaluate how the addition of Imugene to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY